6. Livmorhalskreft (cervixcancer)

Amant, F., Halaska, M. J., Fumagalli, M., Dahl Steffensen, K., Lok, C., Van Calsteren, K., Han, S. N., Mir, O., ... Nulman, I. (2014). Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. International Journal of Gynecological Cancer, 24(3), 394-403.

Andreyev, H. J., Muls, A. C., Norton, C., Ralph, C., Watson, L., Shaw, C., & Lindsay, J. O. (2015). Guidance: The practical management of the gastrointestinal symptoms of pelvic radiation disease. Frontline Gastroenterology, 6(1), 53-72.

Andreyev, H. J., Davidson, S. E., Gillespie, C., Allum, W. H., & Swarbrick, E. (2012). Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut, 61(2), 179-92.

Andreyev, H. J., Benton, B. E., Lalji, A., Norton, C., Mohammed, K., Gage, H., Pennert, K., & Lindsay, J. O. (2013). Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial. Lancet, 382(9910), 2084-92.

Andreyev, H. J., Wotherspoon, A., Denham, J. W., & Hauer-Jensen, M. (2010). Defining pelvic-radiation disease for the survivorship era. Lancet Oncology, 11(4), 310-2.

Anraku, M., Yokoi, K., Nakagawa, K., Fujisawa, T., Nakajima, J., Akiyama, H., Nishimura, Y., & Kobayashi, K. (2004). Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients. Journal of Thoracic and Cardiovascular Surgery, 127(4), 1107-12.

Balleyguier, C., Sala, E., Da Cunha, T., Bergman, A., Brkljacic, B., Danza, F., Forstner, R., Hamm, B., ... Kinkel, K. (2011). Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. European Radiology, 21(5), 1102-10.

Baxter, N. N., Habermann, E. B., Tepper, J. E., Durham, S. B., & Virnig, B. A. (2005). Risk of pelvic fractures in older women following pelvic irradiation. JAMA, 294(20), 2587-93.

Bennett, M. H., Feldmeier, J., Hampson, N. B., Smee, R., & Milross, C. (2016). Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database of Systematic Reviews, (4), CD005005.

Bentivegna, E., Maulard, A., Pautier, P., Chargari, C., Gouy, S., & Morice, P. (2016). Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature. Fertility and Sterility, 106(5), 1195-1211.e5.

Bentivegna, E., Gouy, S., Maulard, A., Chargari, C., Leary, A., & Morice, P. (2016). Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncology, 17(6), e240-e253.

Bentivegna, E., Gouy, S., Maulard, A., Chargari, C., Leary, A., & Morice, P. (2016). Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. The Lancet. Oncology, 17(6), e240-e253.

Bese, N. S., Hendry, J., & Jeremic, B. (2007). Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. International Journal of Radiation Oncology, Biology, Physics, 68(3), 654-61.

Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2018). Cancer of the cervix uteri. International Journal of Gynecology and Obstetrics, 143(Supplement 2), 22-36.

Biglia, N., Zanfagnin, V., Daniele, A., Robba, E., & Bounous, V. E. (2017). Lower Body Lymphedema in Patients with Gynecologic Cancer. Anticancer Research, 37(8), 4005-4015.

Bisharah, M., & Tulandi, T. (2003). Laparoscopic preservation of ovarian function: an underused procedure. American Journal of Obstetrics and Gynecology, 188(2), 367-70.

Bodurka-Bevers, D., Morris, M., Eifel, P. J., Levenback, C., Bevers, M. W., Lucas, K. R., & Wharton, J. T. (2000). Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecologic Oncology, 78(2), 187-93.

Bouchard-Fortier, G., Reade, C. J., & Covens, A. (2014). Non-radical surgery for small early-stage cervical cancer. Is it time?. Gynecologic Oncology, 132(3), 624-7.

Boulware, R. J., Caderao, J. B., Delclos, L., Wharton, J. T., & Peters, L. J. (1979). Whole pelvis megavoltage irradiation with single doses of 1000 rad to palliate advanced gynecologic cancers. International Journal of Radiation Oncology, Biology, Physics, 5(3), 333-8.

Bourgioti, C., Chatoupis, K., & Moulopoulos, L. A. (2016). Current imaging strategies for the evaluation of uterine cervical cancer. World journal of radiology, 8(4), 342-54.

Brooks, R. A., Rader, J. S., Dehdashti, F., Mutch, D. G., Powell, M. A., Thaker, P. H., Siegel, B. A., & Grigsby, P. W. (2009). Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynecologic Oncology, 112(1), 104-9.

Buchali, A., Koswig, S., Dinges, S., Rosenthal, P., Salk, J., Lackner, G., Böhmer, D., Schlenger, L., & Budach, V. (1999). Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynaecological cancer. Radiotherapy and Oncology, 52(1), 29-34.

Casey, S., Harley, I., Jamison, J., Molijn, A., van den Munckhof, H., & McCluggage, W. G. (2015). A rare case of HPV-negative cervical squamous cell carcinoma. International Journal of Gynecological Pathology, 34(2), 208-12.

Cetina, L., Garcia-Arias, A., Uribe Mde, J., Candelaria, M., Rivera, L., Oñate-Ocaña, L., Coronel, J., & Dueñas-Gonzalez, A. (2008). Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer. European Journal of Gynaecological Oncology, 29(6), 608-12.

Chai, Y., Wang, T., Wang, J., Yang, Y., Gao, Y., Gao, J., Gao, S., Wang, Y., ... Liu, Z. (2014). Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer. BMC Cancer, 14, 63.

Charra-Brunaud, C., Harter, V., Delannes, M., Haie-Meder, C., Quetin, P., Kerr, C., Castelain, B., Thomas, L., & Peiffert, D. (2012). Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiotherapy and Oncology, 103(3), 305-13.

Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC) (2010). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database of Systematic Reviews, (1), CD008285.

Chen, X., Zou, H., Li, H., Lin, R., Su, M., Zhang, W., Zhou, Y., Zhang, P., ... Zou, C. (2017). Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer: A Meta-Analysis. International Journal of Gynecological Cancer, 27(2), 344-349.

Chiva, L., Zanagnolo, V., Querleu, D., Martin-Calvo, N., Arévalo-Serrano, J., Căpîlna, M. E., Fagotti, A., Kucukmetin, A., ... Alcazar, J. L. (2020). SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer. International Journal of Gynecological Cancer, 30(9), 1269-1277.

Choi, C. W., Cho, C. K., Yoo, S. Y., Kim, M. S., Yang, K. M., Yoo, H. J., Seo, Y. S., Kang, J. K., ... Kim, B. J. (2009). Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. International Journal of Radiation Oncology, Biology, Physics, 74(1), 147-53.

Chopra, S., Gupta, S., Kannan, S., Dora, T., Engineer, R., Mangaj, A., Maheshwari, A., Shylasree, T. S., ... Shrivastava, S. K. (2021). Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial. Journal of Clinical Oncology, 39(33), 3682-3692.

Chou, H. H., Wang, C. C., Lai, C. H., Hong, J. H., Ng, K. K., Chang, T. C., Tseng, C. J., Tsai, C. S., & Chang, J. T. (2001). Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma. International Journal of Radiation Oncology, Biology, Physics, 51(2), 442-8.

Chung, H. H., Kim, S. K., Kim, T. H., Lee, S., Kang, K. W., Kim, J. Y., & Park, S. Y. (2006). Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. Gynecologic Oncology, 103(1), 165-70.

Cibula, D., & McCluggage, W. G. (2019). Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. Gynecologic Oncology, 152(1), 202-207.

Cibula, D., Pötter, R., Planchamp, F., Avall-Lundqvist, E., Fischerova, D., Haie Meder, C., Köhler, C., Landoni, F., ... Raspollini, M. R. (2018). The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Radiotherapy and Oncology, 127(3), 404-416.

Cibula, D., Rosaria Raspollini, M., Planchamp, F., Centeno, C., Chargari, C., Felix, A., Fischerová, D., Jahnn-Kuch, D., ... Lindegaard, J. (2023). ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023. Radiotherapy and Oncology, 184, 109682.

Cibula, D., Pötter, R., Planchamp, F., Avall-Lundqvist, E., Fischerova, D., Haie-Meder, C., Köhler, C., Landoni, F., ... Raspollini, M. R. (2018). The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer. Virchows Archiv, 472(6), 919-936.

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer [pågående studie] (2012-2018). (NCT01414608). Hentet fra https://clinicaltrials.gov/study/NCT01414608

Clarke, R. E., Tenorio, L. M., Hussey, J. R., Toklu, A. S., Cone, D. L., Hinojosa, J. G., Desai, S. P., Dominguez Parra, L., ... Walker, M. B. (2008). Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. International Journal of Radiation Oncology, Biology, Physics, 72(1), 134-143.

Colombo, N., Dubot, C., Lorusso, D., Caceres, M. V., Hasegawa, K., Shapira-Frommer, R., Tewari, K. S., Salman, P., ... Monk, B. J. (2021). Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer. New England Journal of Medicine, 385(20), 1856-1867.

D'Souza, D. P., Rumble, R. B., Fyles, A., Yaremko, B., & Warde, P. (2012). Intensity-modulated radiotherapy in the treatment of gynaecological cancers. Clinical Oncology (Royal College of Radiologists), 24(7), 499-507.

Das, P., Delclos, M. E., Skibber, J. M., Rodriguez-Bigas, M. A., Feig, B. W., Chang, G. J., Eng, C., Bedi, M., ... Crane, C. H. (2010). Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. International Journal of Radiation Oncology, Biology, Physics, 77(1), 60-5.

Davis, S. R., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., Braunstein, G. D., Hirschberg, A. L., ... Studd, J. (2008). Testosterone for low libido in postmenopausal women not taking estrogen. New England Journal of Medicine, 359(19), 2005-17.

Dawson, L. A., Kavanagh, B. D., Paulino, A. C., Das, S. K., Miften, M., Li, X. A., Pan, C., Ten Haken, R. K., & Schultheiss, T. E. (2010). Radiation-Associated Kidney Injury. International Journal of Radiation Oncology Biology Physics, 76(3 SUPPL.), S108-S115.

de Araujo Souza, P. S., Sichero, L., & Maciag, P. C. (2009). HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncology (London, England), 5(3), 359-70.

Deng, T., Gu, S., Wu, J., & Yu, Y. (2022). Comparison of platinum monotherapy with concurrent chemoradiation therapy versus platinum-based dual drug therapy with concurrent chemoradiation therapy for locally advanced cervical cancer: a systematic review and meta-analysis. Infectious Agents and Cancer, 17(1), 18.

Dillner, J., Kallings, I., Brihmer, C., Sikström, B., Koskela, P., Lehtinen, M., Schiller, J. T., Sapp, M., & Mardh, P. A. (1996). Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. Journal of Infectious Diseases, 173(6), 1394-8.

Dimopoulos, J. C., Kirisits, C., Petric, P., Georg, P., Lang, S., Berger, D., & Pötter, R. (2006). The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. International Journal of Radiation Oncology, Biology, Physics, 66(1), 83-90.

Dubay, R. A., Rose, P. G., O'Malley, D. M., Shalodi, A. D., Ludin, A., & Selim, M. A. (2004). Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. Gynecologic Oncology, 94(1), 121-4.

Dueñas-González, A., Zarbá, J. J., Patel, F., Alcedo, J. C., Beslija, S., Casanova, L., Pattaranutaporn, P., Hameed, S., ... Orlando, M. (2011). Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. Journal of Clinical Oncology, 29(13), 1678-85.

Eifel, P. J., Jhingran, A., Bodurka, D. C., Levenback, C., & Thames, H. (2002). Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. Journal of Clinical Oncology, 20(17), 3651-7.

Einhorn, L. H., Rapoport, B., Navari, R. M., Herrstedt, J., & Brames, M. J. (2017). 2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. Supportive Care in Cancer, 25(1), 303-308.

Elit, L., Fyles, A. W., Devries, M. C., Oliver, T. K., & Fung-Kee-Fung, M. (2009). Follow-up for women after treatment for cervical cancer: a systematic review. Gynecologic Oncology, 114(3), 528-35.

Engesæter, B., Groeneveld, L. F., Skare, G. B., Tropé, A. (2022). Årsrapport 2021: screeningaktivitet og resultater fra Livmorhalsprogrammet Oslo: Kreftregisteret. Hentet fra https://www.kreftregisteret.no/globalassets/livmorhalsprogrammet/rapporter/arsrapport-lp/arsrapportlp_2021_final2.pdf

Engesæter, B., Hverven, S. K., Skare, G. B., Tropé, A. (2023). Årsrapport 2022: screeningaktivitet og resultater fra Livmorhalsprogrammet Oslo: Kreftregisteret. Hentet fra https://www.kreftregisteret.no/globalassets/livmorhalsprogrammet/rapporter/arsrapport-lp/arsrapportlp2022.pdf

Erridge, S. C., Kerr, G. R., Downing, D., Duncan, W., & Price, A. (2002). The effect of overall treatment time on the survival and toxicity of radical radiotherapy for cervical carcinoma. Radiotherapy and Oncology, 63(1), 59-66.

Estape, R. E., Angioli, R., Madrigal, M., Janicek, M., Gomez, C., Penalver, M., & Averette, H. (1998). Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecologic Oncology, 68(3), 229-32.

Favero, G., Chiantera, V., Oleszczuk, A., Gallotta, V., Hertel, H., Herrmann, J., Marnitz, S., Köhler, C., & Schneider, A. (2010). Invasive cervical cancer during pregnancy: laparoscopic nodal evaluation before oncologic treatment delay. Gynecologic Oncology, 118(2), 123-7.

Ferreira, M. R., Muls, A., Dearnaley, D. P., & Andreyev, H. J. (2014). Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist. Lancet Oncology, 15(3), e139-47.

Fokdal, L., Tanderup, K., Pötter, R., Sturdza, A., Kirchheiner, K., Chargari, C., Jürgenliemk-Schulz, I. M., Segedin, B., ... Lindegaard, J. C. (2019). Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies. International Journal of Radiation Oncology, Biology, Physics, 103(4), 887-894.

Fokdal, L., Pötter, R., Kirchheiner, K., Lindegaard, J. C., Jensen, N. B. K., Kirisits, C., Chargari, C., Mahantshetty, U., ... Tanderup, K. (2018). Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer. Radiotherapy and Oncology, 127(3), 423-430.

Fokdal, L., Sturdza, A., Mazeron, R., Haie-Meder, C., Tan, L. T., Gillham, C., Šegedin, B., Jürgenliemk-Schultz, I., ... Tanderup, K. (2016). Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. Radiotherapy and Oncology, 120(3), 434-440.

Fokdal, L., Tanderup, K., Hokland, S. B., Røhl, L., Pedersen, E. M., Nielsen, S. K., Paludan, M., & Lindegaard, J. C. (2013). Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiotherapy and Oncology, 107(1), 63-8.

Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., ... Franceschi, S. (2012). Global burden of human papillomavirus and related diseases. Vaccine, 30 Suppl 5, F12-23.

Frumovitz, M., Munsell, M. F., Burzawa, J. K., Byers, L. A., Ramalingam, P., Brown, J., & Coleman, R. L. (2017). Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. Gynecologic Oncology, 144(1), 46-50.

Fyles, A., Keane, T. J., Barton, M., & Simm, J. (1992). The effect of treatment duration in the local control of cervix cancer. Radiotherapy and Oncology, 25(4), 273-9.

Gadducci, A., Barsotti, C., Cosio, S., Domenici, L., & Riccardo Genazzani, A. (2011). Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecological Endocrinology, 27(8), 597-604.

Gandhi, A. K., Sharma, D. N., Rath, G. K., Julka, P. K., Subramani, V., Sharma, S., Manigandan, D., Laviraj, M. A., ... Thulkar, S. (2013). Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study. International Journal of Radiation Oncology, Biology, Physics, 87(3), 542-8.

Garcia-Duran, C., Grau, F., Villacampa, G., & Oaknin, A. (2022). ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation. International Journal of Gynecological Cancer, , Epub ahead of print.

Gill, B. S., Lin, J. F., Krivak, T. C., Sukumvanich, P., Laskey, R. A., Ross, M. S., Lesnock, J. L., & Beriwal, S. (2014). National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements. International Journal of Radiation Oncology, Biology, Physics, 90(5), 1083-90.

Girinsky, T., Rey, A., Roche, B., Haie, C., Gerbaulet, A., Randrianarivello, H., & Chassagne, D. (1993). Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. International Journal of Radiation Oncology, Biology, Physics, 27(5), 1051-6.

Glover, M., Smerdon, G. R., Andreyev, H. J., Benton, B. E., Bothma, P., Firth, O., Gothard, L., Harrison, J., ... Yarnold, J. (2016). Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial. Lancet Oncology, 17(2), 224-233.

Gravitt, P. E. (2011). The known unknowns of HPV natural history. Journal of Clinical Investigation, 121(12), 4593-9.

Green, J. A., Kirwan, J. M., Tierney, J. F., Symonds, P., Fresco, L., Collingwood, M., & Williams, C. J. (2001). Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet, 358(9284), 781-6.

Grigsby, P. W. (2007). The role of FDG-PET/CT imaging after radiation therapy. Gynecologic Oncology, 107(1 Suppl 1), S27-9.

Guckenberger, M., Bachmann, J., Wulf, J., Mueller, G., Krieger, T., Baier, K., Richter, A., Wilbert, J., & Flentje, M. (2010). Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. Radiotherapy and Oncology, 94(1), 53-9.

Gupta, S., Maheshwari, A., Parab, P., Mahantshetty, U., Hawaldar, R., Sastri Chopra, S., Kerkar, R., Engineer, R., ... Badwe, R. (2018). Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. Journal of Clinical Oncology, 36(16), 1548-1555.

Guren, M. G., Undseth, C., Rekstad, B. L., Brændengen, M., Dueland, S., Spindler, K. L., Glynne-Jones, R., & Tveit, K. M. (2014). Reirradiation of locally recurrent rectal cancer: a systematic review. Radiotherapy and Oncology, 113(2), 151-7.

Haie-Meder, C., Pötter, R., Van Limbergen, E., Briot, E., De Brabandere, M., Dimopoulos, J., Dumas, I., Hellebust, T. P., ... Wachter-Gerstner, N. (2005). Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiotherapy and Oncology, 74(3), 235-45.

Halaska, M. J., Rob, L., Robova, H., & Cerny, M. (2016). Treatment of gynecological cancers diagnosed during pregnancy. Future Oncology (London, England), 12(19), 2265-75.

Haldorsen, I. S., Lura, N., Blaakær, J., Fischerova, D., & Werner, H. M. J. (2019). What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?. Current Oncology Reports, 21(9), 77.

Halle, J. S., Rosenman, J. G., Varia, M. A., Fowler, W. C., Walton, L. A., & Currie, J. L. (1986). 1000 cGy single dose palliation for advanced carcinoma of the cervix or endometrium. International Journal of Radiation Oncology, Biology, Physics, 12(11), 1947-50.

Hartman, C. A., Teixeira, J. C., Barbosa, S. B., Figueiredo, S. M., Andrade, L. A., & Bastos, J. F. (2017). Analysis of Conservative Surgical Treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years. International Journal of Gynecological Cancer, 27(2), 357-363.

Helsedirektoratet (2016). Pakkeforløp for livmorhalskreft (rev. utg.) (IS-2354). Oslo: Helsedirektoratet. Hentet fra https://helsedirektoratet.no/retningslinjer/pakkeforlop-for-livmorhalskreft

Higham, C. E., & Faithfull, S. (2015). Bone Health and Pelvic Radiotherapy. Clinical Oncology (Royal College of Radiologists), 27(11), 668-78.

Homesley, H. D., Meltzer, N. P., Nieves, L., Vaccarello, L., Lowendowski, G. S., & Elbendary, A. A. (2008). A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer. International Journal of Clinical Oncology, 13(1), 62-5.

Hong, J. H., Tsai, C. S., Lai, C. H., Chang, T. C., Wang, C. C., Chou, H. H., Lee, S. P., & Hsueh, S. (2004). Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 60(1), 249-57.

Horeweg, N., Mittal, P., Gradowska, P. L., Boere, I., Nout, R. A., & Chopra, S. (2022). A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer. Critical Reviews in Oncology/Hematology, 172, 103638.

Huang, E. Y., Wang, C. J., Chen, H. C., Fang, F. M., Huang, Y. J., Wang, C. Y., & Hsu, H. C. (2008). Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix. International Journal of Radiation Oncology, Biology, Physics, 72(3), 834-42.

Huang, Z., Mayr, N. A., Gao, M., Lo, S. S., Wang, J. Z., Jia, G., & Yuh, W. T. (2012). Onset time of tumor repopulation for cervical cancer: first evidence from clinical data. International Journal of Radiation Oncology, Biology, Physics, 84(2), 478-84.

Huang, G., Basaria, S., Travison, T. G., Ho, M. H., Davda, M., Mazer, N. A., Miciek, R., Knapp, P. E., ... Bhasin, S. (2014). Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial. Menopause, 21(6), 612-23.

Hui, B., Zhang, Y., Shi, F., Wang, J., Wang, T., Wang, J., Yuan, W., Li, Y., & Liu, Z. (2014). Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy. International Journal of Gynecological Cancer, 24(9), 1648-52.

Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer (INTERLACE) [pågående studie] (2012-2026). (NCT01566240). Hentet fra https://clinicaltrials.gov/study/NCT01566240

International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer (SENTICOLIII) [pågående studie] (2018-2026). (NCT03386734). Hentet fra https://clinicaltrials.gov/study/NCT03386734

International Agency for Research on Cancer (2022). Cervical Cancer Screening (IARC Handbooks of Cancer Prevention Volume 18). Lyon: IARC. Hentet fra https://publications.iarc.fr/604

International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby, P., Beral, V., Berrington de Gonzalez, A., Colin, D., Franceschi, S., Goodill, A., Green, J., ... Sweetland, S. (2006). Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. International Journal of Cancer, 118(6), 1481-95.

The International Commission on Radiation Units & Measurements (ICRU), & Groupe Européen de Curiethérapie/European Society for Radiotherapy and Oncology (GEC/ESTRO) (2016). ICRU Report 89: Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix. Journal of the ICRU, 13(1-2)

Jensen, N. B. K., Pötter, R., Spampinato, S., Fokdal, L. U., Chargari, C., Lindegaard, J. C., Schmid, M. P., Sturdza, A., ... Tanderup, K. (2021). Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study. International Journal of Radiation Oncology, Biology, Physics, 109(3), 688-700.

Jensen, P. T., Groenvold, M., Klee, M. C., Thranov, I., Petersen, M. A., & Machin, D. (2003). Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. International Journal of Radiation Oncology, Biology, Physics, 56(4), 937-49.

Jensen, N. B. K., Pötter, R., Kirchheiner, K., Fokdal, L., Lindegaard, J. C., Kirisits, C., Mazeron, R., Mahantshetty, U., ... Tanderup, K. (2018). Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study. Radiotherapy and Oncology, 127(3), 431-439.

Joiner, M. C., van der Kogel, A. J. (2019). Basic clinical radiobiology. CRC Press, Taylor & Francis Group.

Jordan, J., Martin-Hirsch, P., Arbyn, M., Schenck, U., Baldauf, J. J., Da Silva, D., Anttila, A., Nieminen, P., & Prendiville, W. (2009). European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology, 20(1), 5-16.

Katanyoo, K., Tangjitgamol, S., Chongthanakorn, M., Tantivatana, T., Manusirivithaya, S., Rongsriyam, K., & Cholpaisal, A. (2011). Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients. Gynecologic Oncology, 123(3), 571-6.

Keenan, L. G., Rock, K., Azmi, A., Salib, O., Gillham, C., & McArdle, O. (2018). An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines. Radiotherapy and Oncology, 127(3), 417-422.

Kenter, G., Greggi, S., Vergote, I., Katsaros, D., Kobierski, J., Massuger, L., Doorn, H. C. v., Landoni, F., ... Casado, A. (2019). Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage Ib2-IIb cervical cancer, EORTC 55994. Journal of Clinical Oncology, 37(15_suppl), 5503.

Keys, H. M., Bundy, B. N., Stehman, F. B., Muderspach, L. I., Chafe, W. E., Suggs, C. L. ,. 3., Walker, J. L., & Gersell, D. (1999). Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New England Journal of Medicine, 340(15), 1154-61.

Khanna, N., Rauh, L. A., Lachiewicz, M. P., & Horowitz, I. R. (2016). Margins for cervical and vulvar cancer. Journal of Surgical Oncology, 113(3), 304-9.

Kim, D. H., Lee, J. H., Ki, Y. K., Nam, J. H., Kim, W. T., Jeon, H. S., Park, D., & Kim, D. W. (2013). Short-course palliative radiotherapy for uterine cervical cancer. Radiation Oncology Journal, 31(4), 216-21.

Kirchheiner, K., Nout, R. A., Lindegaard, J. C., Haie-Meder, C., Mahantshetty, U., Segedin, B., Jürgenliemk-Schulz, I. M., Hoskin, P. J., ... Tanderup, K. (2016). Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiotherapy and Oncology, 118(1), 160-6.

Kitagawa, R., Katsumata, N., Shibata, T., Kamura, T., Kasamatsu, T., Nakanishi, T., Nishimura, S., Ushijima, K., ... Yoshikawa, H. (2015). Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505. Journal of Clinical Oncology, 33(19), 2129-35.

Kjellberg, L., Hallmans, G., Ahren, A. M., Johansson, R., Bergman, F., Wadell, G., Angstrom, T., & Dillner, J. (2000). Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. British Journal of Cancer, 82(7), 1332-8.

Klopp, A. H., Yeung, A. R., Deshmukh, S., Gil, K. M., Wenzel, L., Westin, S. N., Gifford, K., Gaffney, D. K., ... Bruner, D. W. (2018). Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. Journal of Clinical Oncology, 36(24), 2538-2544.

Kreftregisteret ([s.a.]). KREMT - Kreftregisterets Elektroniske Meldetjeneste [webbasert portal] Oslo: Kreftregisteret. Hentet fra https://portal.kreftregistrering.no/

Kreftregisteret (2022). Årsrapport 2021 med resultater og forbedringstiltak fra Nasjonalt kvalitetsregister for gynekologisk kreft Oslo: Kreftregisteret. Hentet fra https://www.kvalitetsregistre.no/sites/default/files/2022-06/%C3%85rsrapport%202021%20Nasjonalt%20kvalitetsregister%20for%20gynekologisk%20kreft.pdf

Kristensen, G. B.. (1999). Studies on prognostic factors in cervical cancer with special attention to early disease (doktorgrad.). University of Oslo, Oslo.

Kupets, R., Thomas, G. M., & Covens, A. (2002). Is there a role for pelvic lymph node debulking in advanced cervical cancer?. Gynecologic Oncology, 87(2), 163-70.

Lanceley, A., Fiander, A., McCormack, M., & Bryant, A. (2013). Follow-up protocols for women with cervical cancer after primary treatment. Cochrane Database of Systematic Reviews, (11), CD008767.

Landoni, F., Maneo, A., Colombo, A., Placa, F., Milani, R., Perego, P., Favini, G., Ferri, L., & Mangioni, C. (1997). Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet, 350(9077), 535-40.

Larsen, I. K. (2022). Cancer in Norway 2021: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.

Larsen, I. K. (2024). Cancer in Norway 2023: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.

Laursen, L. V., Elstrøm, U. V., Vestergaard, A., Muren, L. P., Petersen, J. B., Lindegaard, J. C., Grau, C., & Tanderup, K. (2012). Residual rotational set-up errors after daily cone-beam CT image guided radiotherapy of locally advanced cervical cancer. Radiotherapy and Oncology, 105(2), 220-5.

Law, E., Kelvin, J. F., Thom, B., Riedel, E., Tom, A., Carter, J., Alektiar, K. M., & Goodman, K. A. (2015). Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiotherapy and Oncology, 116(1), 149-55.

Lee, S. H., Lee, S. H., Lee, K. C., Lee, K. B., Shin, J. W., Park, C. Y., Sym, S. J., & Lee, J. H. (2012). Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement. Journal of Gynecologic Oncology, 23(3), 159-67.

Lee, S. I., & Atri, M. (2019). 2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging. Radiology, 292(1), 15-24.

Levernes, S. (2012). Volum og doser i ekstern stråleterapi: definisjoner og anbefalinger (StrålevernRapport 2012:9). Østerås: Statens strålevern. Hentet fra https://dsa.no/publikasjoner/stralevernrapport-9-2012-volum-og-doser-i-ekstern-straleterapi/StralevernRapport_09-2012.pdf

Levernes, S. (2019). Nomenklatur for volumer i stråleterapi (Teknisk dokument 14). Østerås: Direktoratet for strålevern og atomsikkerhet. Hentet fra https://dsa.no/medisinsk-stralebruk/kvist/_/attachment/download/2f7317b7-e2f3-423e-b388-7d1d8d07b271:e947e054b123c9af0fa0fae10c867ce43e3d149e/TekniskDokument14.pdf

Liem, X., Saad, F., & Delouya, G. (2015). A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis. Drugs, 75(13), 1471-82.

Lim, M. C., Lee, H. S., Seo, S. S., Kim, M. S., Kim, J. Y., Zo, J. I., & Park, S. Y. (2010). Pathologic diagnosis and resection of suspicious thoracic metastases in patients with cervical cancer through thoracotomy or video-assisted thoracic surgery. Gynecologic Oncology, 116(3), 478-82.

Lim, K., Small, W. ,. J., Portelance, L., Creutzberg, C., Jürgenliemk-Schulz, I. M., Mundt, A., Mell, L. K., Mayr, N., ... Fyles, A. (2011). Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. International Journal of Radiation Oncology, Biology, Physics, 79(2), 348-55.

Lindegaard, J. C., Fokdal, L. U., Nielsen, S. K., Juul-Christensen, J., & Tanderup, K. (2013). MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncologica, 52(7), 1510-9.

Maeda, Y., Høyer, M., Lundby, L., Buntzen, S., & Laurberg, S. (2010). Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy. Radiotherapy and Oncology, 97(1), 108-12.

Manganaro, L., Lakhman, Y., Bharwani, N., Gui, B., Gigli, S., Vinci, V., Rizzo, S., Kido, A., ... Nougaret, S. (2021). Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. European Radiology, 31(10), 7802-7816.

Marnitz, S., Wlodarczyk, W., Neumann, O., Koehler, C., Weihrauch, M., Budach, V., & Cozzi, L. (2015). Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison. Radiation Oncology (London, England), 10, 91.

Matsuoka, H., Nakamura, K., Matsubara, Y., Ida, N., Saijo, M., Ogawa, C., & Masuyama, H. (2018). The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer Survivors. International Journal of Gynecological Cancer, 28(7), 1394-1402.

Mayadev, J., Nunes, A. T., Li, M., Marcovitz, M., Lanasa, M. C., & Monk, B. J. (2020). CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study. International Journal of Gynecological Cancer, 30(7), 1065-1070.

Mazeron, R., Castelnau-Marchand, P., Dumas, I., del Campo, E. R., Kom, L. K., Martinetti, F., Farha, G., Tailleur, A., ... Haie-Meder, C. (2015). Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy. Radiotherapy and Oncology, 114(2), 257-63.

McCann, G. A., Taege, S. K., Boutsicaris, C. E., Phillips, G. S., Eisenhauer, E. L., Fowler, J. M., O'Malley, D. M., Copeland, L. J., ... Salani, R. (2013). The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer. Gynecologic Oncology, 128(1), 44-48.

Mehmood, Q., Beardwood, M., Swindell, R., Greenhalgh, S., Wareham, T., Barraclough, L., Livsey, J., & Davidson, S. E. (2014). Insufficiency fractures in patients treated with pelvic radiotherapy and chemotherapy for uterine and cervical cancer. European Journal of Cancer Care (English Language Edition), 23(1), 43-50.

Miles, T., & Johnson, N. (2014). Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database of Systematic Reviews, (9), CD007291.

Mileshkin, L. R., Moore, K. N., Barnes, E., Gebski, V., Narayan, K., Bradshaw, N., Lee, Y. C., Diamante, K., ... Monk, B. J. (2021). Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274). Journal of Clinical Oncology, 39(18_suppl), LBA3.

Mohamed, S. M., Aagaard, T., Fokdal, L. U., Pedersen, E. M., Lindegaard, J. C., & Tanderup, K. (2015). Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer. Brachytherapy, 14(1), 56-61.

Mohamed, S., Lindegaard, J. C., de Leeuw, A. A., Jürgenliemk-Schulz, I., Kirchheiner, K., Kirisits, C., Pötter, R., & Tanderup, K. (2016). Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer. Radiotherapy and Oncology, 120(3), 480-485.

Morice, P., Castaigne, D., Haie-Meder, C., Pautier, P., El Hassan, J., Duvillard, P., Gerbaulet, A., & Michel, G. (1998). Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertility and Sterility, 70(5), 956-60.

Morrison, C., Catania, F., Wakely, P. ,. J., & Nuovo, G. J. (2001). Highly differentiated keratinizing squamous cell cancer of the cervix: a rare, locally aggressive tumor not associated with human papillomavirus or squamous intraepithelial lesions. American Journal of Surgical Pathology, 25(10), 1310-5.

Muehlbauer, P. M., Thorpe, D., Davis, A., Drabot, R., Rawlings, B. L., & Kiker, E. (2009). Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy- and radiotherapy-induced diarrhea. Clinical Journal of Oncology Nursing, 13(3), 336-41.

Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J., Meijer, C. J., & International Agency for Research on Cancer Multicenter Cervical Cancer Study Group (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine, 348(6), 518-27.

Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine, 24 Suppl 3, S3/1-10.

Najjari Jamal, D., Pötter, R., Haie-Meder, C., Lindegaard, J. C., Juergenliemk-Schulz, I. M., Mahantshetty, U., Segedin, B., Bruheim, K., ... Kirchheiner, K. (2018). Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study. Radiotherapy and Oncology, 127(3), 449-455.

Nam, E. J., Lee, M., Yim, G. W., Kim, J. H., Kim, S., Kim, S. W., Kim, J. W., & Kim, Y. T. (2013). Comparison of carboplatin- and cisplatin-based concurrent chemoradiotherapy in locally advanced cervical cancer patients with morbidity risks. Oncologist, 18(7), 843-9.

Niibe, Y., Kazumoto, T., Toita, T., Yamazaki, H., Higuchi, K., Ii, N., Suzuki, K., Uno, T., ... Hayakawa, K. (2006). Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study. Gynecologic Oncology, 103(2), 435-8.

Niibe, Y., Kenjo, M., Kazumoto, T., Michimoto, K., Takayama, M., Yamauchi, C., Kataoka, M., Suzuki, K., ... Hayakawa, K. (2006). Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000. International Journal of Radiation Oncology, Biology, Physics, 66(5), 1366-9.

Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months (NiCOL) [pågående studie] (2017-2022). (NCT03298893). Hentet fra https://clinicaltrials.gov/study/NCT03298893

Nomden, C. N., Pötter, R., de Leeuw, A. A. C., Tanderup, K., Lindegaard, J. C., Schmid, M. P., Fortin, I., Haie-Meder, C., ... Jürgenliemk-Schulz, I. M. (2019). Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort. Radiotherapy and Oncology, 134, 185-190.

Onsrud, M., Hagen, B., & Strickert, T. (2001). 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri. Gynecologic Oncology, 82(1), 167-71.

Oonk, M. H. M., Planchamp, F., Baldwin, P., Bidzinski, M., Brannstrom, M., Landoni, F., Mahner, S., Mahantshetty, U., ... van der Zee, A. G. J. (2017). European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer. International Journal of Gynecological Cancer, 27(4), 832-837.

Oscarsson, N., Müller, B., Rosén, A., Lodding, P., Mölne, J., Giglio, D., Hjelle, K. M., Vaagbø, G., ... Seeman-Lodding, H. (2019). Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial. Lancet Oncology, 20(11), 1602-1614.

Oslo universitetssykehus ([s.a.]). OUS Prosedyre: ultrastaging SN for gynekologiske preparater Oslo: OUS, Klinikk for laboratoriemedisin (KLM)/ Avd. patologi/Histologi.

Panay, N., & Kalu, E. (2009). Management of premature ovarian failure. Best Practice & Research: Clinical Obstetrics & Gynaecology, 23(1), 129-40.

Park, K. J. (2020). Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification. Histopathology, 76(1), 112-127.

Perez, C. A., Grigsby, P. W., Castro-Vita, H., & Lockett, M. A. (1995). Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 32(5), 1275-88.

Peters, W. A., Liu, P. Y., Barrett, R. J., Stock, R. J., Monk, B. J., Berek, J. S., Souhami, L., Grigsby, P., ... Alberts, D. S. (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Journal of Clinical Oncology, 18(8), 1606-13.

Pieterse, Q. D., Kenter, G. G., Maas, C. P., de Kroon, C. D., Creutzberg, C. L., Trimbos, J. B., & Ter Kuile, M. M. (2013). Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. International Journal of Gynecological Cancer, 23(9), 1717-25.

Plante, M. (2013). Evolution in fertility-preserving options for early-stage cervical cancer: radical trachelectomy, simple trachelectomy, neoadjuvant chemotherapy. International Journal of Gynecological Cancer, 23(6), 982-9.

Pötter, R., Tanderup, K., Kirisits, C., de Leeuw, A., Kirchheiner, K., Nout, R., Tan, L. T., Haie-Meder, C., ... Jürgenliemk-Schulz, I. (2018). The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clinical and translational radiation oncology, 9, 48-60.

Pötter, R., Tanderup, K., Schmid, M. P., Jürgenliemk-Schulz, I., Haie-Meder, C., Fokdal, L. U., Sturdza, A. E., Hoskin, P., ... Lindegaard, J. C. (2021). MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncology, 22(4), 538-547.

Ramirez, P. T., Frumovitz, M., Pareja, R., Lopez, A., Vieira, M., Ribeiro, R., Buda, A., Yan, X., ... Obermair, A. (2018). Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. New England Journal of Medicine, 379(20), 1895-1904.

Ramlov, A., Pedersen, E. M., Røhl, L., Worm, E., Fokdal, L., Lindegaard, J. C., & Tanderup, K. (2017). Risk Factors for Pelvic Insufficiency Fractures in Locally Advanced Cervical Cancer Following Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 97(5), 1032-1039.

Ramlov, A., Assenholt, M. S., Jensen, M. F., Grønborg, C., Nout, R., Alber, M., Fokdal, L., Tanderup, K., & Lindegaard, J. C. (2017). Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer. Radiotherapy and Oncology, 123(1), 158-163.

Rijkmans, E. C., Nout, R. A., Rutten, I. H., Ketelaars, M., Neelis, K. J., Laman, M. S., Coen, V. L., Gaarenstroom, K. N., ... Creutzberg, C. L. (2014). Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecologic Oncology, 135(2), 231-8.

Rodriguez, J., Viveros-Carreno, D., & Pareja, R. (2022). Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update?. International Journal of Gynecological Cancer, 32(10), 1219-1226.

Rogers, L., Siu, S. S., Luesley, D., Bryant, A., & Dickinson, H. O. (2012). Radiotherapy and chemoradiation after surgery for early cervical cancer. Cochrane Database of Systematic Reviews, (5), CD007583.

Rotman, M., Sedlis, A., Piedmonte, M. R., Bundy, B., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (2006). A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. International Journal of Radiation Oncology, Biology, Physics, 65(1), 169-76.

Royal College of Radiologists (2019). The timely delivery of radical radiotherapy: standards and guidelines for the management of unscheduled treatment interruptions (4 utg.) London: The Royal College of Radiologists. Hentet fra https://www.rcr.ac.uk/publication/timely-delivery-radical-radiotherapy-guidelines-management-unscheduled-treatment

Rud, A. K., Bjørgo, S., Kristensen, G. B., & Kongsgaard, U. E. (2009). Hyperbaric oxygen therapy for late radiation tissue injury in gynaecological patients. Supportive Care in Cancer, 17(12), 1517-21.

Rydzewska, L., Tierney, J., Vale, C. L., & Symonds, P. R. (2012). Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database of Systematic Reviews, (12), CD007406.

Salani, R., Backes, F. J., Fung, M. F., Holschneider, C. H., Parker, L. P., Bristow, R. E., & Goff, B. A. (2011). Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. American Journal of Obstetrics and Gynecology, 204(6), 466-78.

Salvo, G., Gonzalez Martin, A., Gonzales, N. R., & Frumovitz, M. (2019). Updates and management algorithm for neuroendocrine tumors of the uterine cervix. International Journal of Gynecological Cancer, 29(6), 986-995.

Satoh, T., Takei, Y., Treilleux, I., Devouassoux-Shisheboran, M., Ledermann, J., Viswanathan, A. N., Mahner, S., Provencher, D. M., ... Fujiwara, K. (2014). Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix. International Journal of Gynecological Cancer, 24(9 Suppl 3), S102-8.

Schiffman, M., & Wentzensen, N. (2010). From human papillomavirus to cervical cancer. Obstetrics and Gynecology, 116(1), 177-85.

Schmid, M. P., Franckena, M., Kirchheiner, K., Sturdza, A., Georg, P., Dörr, W., & Pötter, R. (2014). Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy. Gynecologic Oncology, 133(2), 256-62.

Sedlis, A., Bundy, B. N., Rotman, M. Z., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (1999). A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecologic Oncology, 73(2), 177-83.

Sekretariatet for nye metoder (28. september 2022). Pembrolizumab (Keytruda) - Indikasjon XXII. [nettdokument]. Oslo: Nye metoder. Hentet 30. november 2022 fra https://nyemetoder.no/metoder/pembrolizumab-keytruda-indikasjon-xxiii

Sekretariatet for nye metoder (24. juni 2022). Cemiplimab (Libtayo) - Indikasjon IV. [nettdokument]. Oslo: Nye metoder. Hentet 30. november 2022 fra https://nyemetoder.no/metoder/cemiplimab-libtayo-indikasjon-iv

Sentinel Lymph Node Biopsy in Patients With Early Stages Cervical Cancer (SENTIX) [pågående studie] (2016-2022). (NCT02494063). Hentet fra https://clinicaltrials.gov/study/NCT02494063

Sert, B. M., Kristensen, G. B., Kleppe, A., & Dørum, A. (2021). Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience. Gynecologic Oncology, 162(2), 284-291.

Singh, A. K., Grigsby, P. W., Rader, J. S., Mutch, D. G., & Powell, M. A. (2005). Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. International Journal of Radiation Oncology, Biology, Physics, 61(2), 450-5.

Small, W. ,. J., Mell, L. K., Anderson, P., Creutzberg, C., De Los Santos, J., Gaffney, D., Jhingran, A., Portelance, L., ... Mundt, A. J. (2008). Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. International Journal of Radiation Oncology, Biology, Physics, 71(2), 428-34.

Smet, S., Pötter, R., Haie-Meder, C., Lindegaard, J. C., Schulz-Juergenliemk, I., Mahantshetty, U., Segedin, B., Bruheim, K., ... Kirchheiner, K. (2018). Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study. Radiotherapy and Oncology, 127(3), 440-448.

Smith, E. S., Moon, A. S., O'Hanlon, R., Leitao, M. M. ,. J., Sonoda, Y., Abu-Rustum, N. R., & Mueller, J. J. (2020). Radical Trachelectomy for the Treatment of Early-Stage Cervical Cancer: A Systematic Review. Obstetrics and Gynecology, 136(3), 533-542.

Soutter, W. P., Haidopoulos, D., Gornall, R. J., McIndoe, G. A., Fox, J., Mason, W. P., Flanagan, A., Nicholas, N., ... Sarhanis, P. (2001). Is conservative treatment for adenocarcinoma in situ of the cervix safe?. BJOG: An International Journal of Obstetrics and Gynaecology, 108(11), 1184-9.

Spampinato, S., Jensen, N. B. K., Pötter, R., Fokdal, L. U., Chargari, C., Lindegaard, J. C., Schmid, M. P., Sturdza, A., ... Embrace Collaborative, G. (2022). Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future. International Journal of Radiation Oncology, Biology, Physics, 112(3), 681-693.

Spampinato, S., Fokdal, L. U., Pötter, R., Haie-Meder, C., Lindegaard, J. C., Schmid, M. P., Sturdza, A., Jürgenliemk-Schulz, I. M., ... Tanderup, K. (2021). Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis. Radiotherapy and Oncology, 158, 312-320.

Spampinato, S., Fokdal, L. U., Pötter, R., Haie-Meder, C., Lindegaard, J. C., Schmid, M. P., Sturdza, A., Jürgenliemk-Schulz, I. M., ... Tanderup, K. (2021). Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis. Radiotherapy and Oncology, 158, 300-308.

Spanos, W. J. ,. J., Wasserman, T., Meoz, R., Sala, J., Kong, J., & Stetz, J. (1987). Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: final report of RTOG phase I/II study. International Journal of Radiation Oncology, Biology, Physics, 13(10), 1479-82.

Stanley, M. (2010). Pathology and epidemiology of HPV infection in females. Gynecologic Oncology, 117(2 Suppl), S5-10.

Steen, R., Dahl, A. A., Hess, S. L., & Kiserud, C. E. (2017). A study of chronic fatigue in Norwegian cervical cancer survivors. Gynecologic Oncology, 146(3), 630-635.

Sturdza, A., Pötter, R., Fokdal, L. U., Haie-Meder, C., Tan, L. T., Mazeron, R., Petric, P., Šegedin, B., ... Lindegaard, J. C. (2016). Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiotherapy and Oncology, 120(3), 428-433.

Taarnhøj, G. A., Christensen, I. J., Lajer, H., Fuglsang, K., Jeppesen, M. M., Kahr, H. S., & Høgdall, C. (2018). Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study. Cancer, 124(5), 943-951.

Tan, L. T., Pötter, R., Sturdza, A., Fokdal, L., Haie-Meder, C., Schmid, M., Gregory, D., Petric, P., ... Tanderup, K. (2019). Change in Patterns of Failure After Image-Guided Brachytherapy for Cervical Cancer: Analysis From the RetroEMBRACE Study. International Journal of Radiation Oncology, Biology, Physics, 104(4), 895-902.

Tanderup, K., Fokdal, L. U., Sturdza, A., Haie-Meder, C., Mazeron, R., van Limbergen, E., Jürgenliemk-Schulz, I., Petric, P., ... Pötter, R. (2016). Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiotherapy and Oncology, 120(3), 441-446.

Tang, J., Tang, Y., Yang, J., & Huang, S. (2012). Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma. Gynecologic Oncology, 125(2), 297-302.

Tangjitgamol, S., Katanyoo, K., Laopaiboon, M., Lumbiganon, P., Manusirivithaya, S., & Supawattanabodee, B. (2014). Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. Cochrane Database of Systematic Reviews, (12), CD010401.

Tangjitgamol, S., Tharavichitkul, E., Tovanabutra, C., Rongsriyam, K., Asakij, T., Paengchit, K., Sukhaboon, J., Penpattanagul, S., ... Lorvidhaya, V. (2019). A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial. Journal of Gynecologic Oncology, 30(4), e82.

Tao, R., Tsai, C. J., Jensen, G., Eng, C., Kopetz, S., Overman, M. J., Skibber, J. M., Rodriguez-Bigas, M., ... Das, P. (2017). Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiotherapy and Oncology, 122(1), 146-151.

Taylor, A., Rockall, A. G., & Powell, M. E. (2007). An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. Clinical Oncology (Royal College of Radiologists), 19(7), 542-50.

Tewari, K. S., Monk, B. J., Vergote, I., Miller, A., de Melo, A. C., Kim, H. S., Kim, Y. M., Lisyanskaya, A., ... Oaknin, A. (2022). Survival with Cemiplimab in Recurrent Cervical Cancer. New England Journal of Medicine, 386(6), 544-555.

Tewari, K. S., Sill, M. W., Long, H. J. ,. 3., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., ... Monk, B. J. (2014). Improved survival with bevacizumab in advanced cervical cancer. New England Journal of Medicine, 370(8), 734-43.

Tharavichitkul, E., Lorvidhaya, V., Kamnerdsupaphon, P., Sukthomya, V., Chakrabandhu, S., Klunklin, P., Onchan, W., Supawongwattana, B., ... Chitapanarux, I. (2016). Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand. BMC Cancer, 16, 501.

Toita, T., Ohno, T., Kaneyasu, Y., Kato, T., Uno, T., Hatano, K., Norihisa, Y., Kasamatsu, T., ... Hiraoka, M. (2011). A consensus-based guideline defining clinical target volume for primary disease in external beam radiotherapy for intact uterine cervical cancer. Japanese Journal of Clinical Oncology, 41(9), 1119-26.

Toita, T., Ohno, T., Kaneyasu, Y., Uno, T., Yoshimura, R., Kodaira, T., Furutani, K., Kasuya, G., ... Hiraoka, M. (2010). A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer. Japanese Journal of Clinical Oncology, 40(5), 456-63.

Tseng, J. H., Aloisi, A., Sonoda, Y., Gardner, G. J., Zivanovic, O., Abu-Rustum, N. R., & Leitao, M. M. ,. J. (2018). Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival. Gynecologic Oncology, 150(1), 44-49.

U.S. Department of Health and Human Services (2017). Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 Washington, D.C.: U.S. Department of Health and Human Services. Hentet fra https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf

Vaccarella, S., Herrero, R., Snijders, P. J., Dai, M., Thomas, J. O., Hieu, N. T., Ferreccio, C., Matos, E., ... Franceschi, S. (2008). Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. International Journal of Epidemiology, 37(3), 536-46.

van de Wetering, F. T., Verleye, L., Andreyev, H. J., Maher, J., Vlayen, J., Pieters, B. R., van Tienhoven, G., & Scholten, R. J. (2016). Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis. Cochrane Database of Systematic Reviews, (4), CD003455.

Van de Putte, G., Lie, A. K., Vach, W., Baekelandt, M., & Kristensen, G. B. (2005). Risk grouping in stage IB squamous cell cervical carcinoma. Gynecologic Oncology, 99(1), 106-12.

van de Sande, M. A., Creutzberg, C. L., van de Water, S., Sharfo, A. W., & Hoogeman, M. S. (2016). Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?. Radiotherapy and Oncology, 120(3), 397-403.

van Lonkhuijzen, L., & Thomas, G. (2011). Palliative radiotherapy for cervical carcinoma, a systematic review. Radiotherapy and Oncology, 98(3), 287-91.

Vanneste, B. G., Van De Voorde, L., de Ridder, R. J., Van Limbergen, E. J., Lambin, P., & van Lin, E. N. (2015). Chronic radiation proctitis: tricks to prevent and treat. International Journal of Colorectal Disease, 30(10), 1293-303.

Vercellino, G. F., Koehler, C., Erdemoglu, E., Mangler, M., Lanowska, M., Malak, A. H., Schneider, A., & Chiantera, V. (2014). Laparoscopic pelvic lymphadenectomy in 32 pregnant patients with cervical cancer: rationale, description of the technique, and outcome. International Journal of Gynecological Cancer, 24(2), 364-71.

Verma, V., Simone, C. B. ,. 2., Wahl, A. O., Beriwal, S., & Mehta, M. P. (2016). Proton radiotherapy for gynecologic neoplasms. Acta Oncologica, 55(11), 1257-1265.

Vistad, I., Bjørge, L., Solheim, O., Fiane, B., Sachse, K., Tjugum, J., Skrøppa, S., Bentzen, A. G., ... Dørum, A. (2017). A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway. Acta Obstetricia et Gynecologica Scandinavica, 96(10), 1162-1169.

Vistad, I., Fosså, S. D., Kristensen, G. B., & Dahl, A. A. (2007). Chronic fatigue and its correlates in long-term survivors of cervical cancer treated with radiotherapy. BJOG: An International Journal of Obstetrics and Gynaecology, 114(9), 1150-8.

Vistad, I., Kristensen, G. B., Fosså, S. D., Dahl, A. A., & Mørkrid, L. (2009). Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 73(4), 1141-7.

Viswanathan, A. N., & Thomadsen, B. (2012). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy, 11(1), 33-46.

Viswanathan, A. N., Lee, L. J., Eswara, J. R., Horowitz, N. S., Konstantinopoulos, P. A., Mirabeau-Beale, K. L., Rose, B. S., von Keudell, A. G., & Wo, J. Y. (2014). Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer, 120(24), 3870-83.

Viswanathan, A. N., Lee, H., Hanson, E., Berkowitz, R. S., & Crum, C. P. (2006). Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer. International Journal of Radiation Oncology, Biology, Physics, 65(5), 1501-7.

Viswanathan, A. N., Yorke, E. D., Marks, L. B., Eifel, P. J., & Shipley, W. U. (2010). Radiation dose-volume effects of the urinary bladder. International Journal of Radiation Oncology, Biology, Physics, 76(3 Suppl), S116-22.

Vittrup, A. S., Tanderup, K., Bentzen, S. M., Jensen, N. B. K., Spampinato, S., Fokdal, L. U., Lindegaard, J. C., Sturdza, A., ... Kirchheiner, K. (2021). Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study. International Journal of Radiation Oncology, Biology, Physics, 109(1), 161-173.

Wang, Y., Ouyang, Y., Su, J., Liu, J., Cai, Q., Xu, Q., Bai, Z., & Cao, X. (2019). Multicentre, randomised controlled trial of adjuvant chemotherapy in cervical cancer with residual human papilloma virus DNA following primary radiotherapy or chemoradiotherapy: a study protocol. BMJ Open, 9(10), e028171.

Westerveld, H., Kirchheiner, K., Nout, R. A., Tanderup, K., Lindegaard, J. C., Spampinato, S., Sturdza, A., Nesvacil, N., ... de Leeuw, A. A. C. (2022). Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study. Radiotherapy and Oncology, 168, 8-15.

Westin, S. N., Sun, C. C., Tung, C. S., Lacour, R. A., Meyer, L. A., Urbauer, D. L., Frumovitz, M. M., Lu, K. H., & Bodurka, D. C. (2016). Survivors of gynecologic malignancies: impact of treatment on health and well-being. Journal of Cancer Survivorship, 10(2), 261-70.

WHO Classification of Tumours Editorial Board (2020). Female Genital Tumours. International Agency for Research on Cancer.

Willett, C. G., Ooi, C. J., Zietman, A. L., Menon, V., Goldberg, S., Sands, B. E., & Podolsky, D. K. (2000). Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. International Journal of Radiation Oncology, Biology, Physics, 46(4), 995-8.

Wo, J., & Taghian, A. (2007). Radiotherapy in setting of collagen vascular disease. International Journal of Radiation Oncology, Biology, Physics, 69(5), 1347-53.

Yalvac, S., Kayikcioglu, F., Boran, N., Tulunay, G., Kose, M. F., Bilgic, S., & Haberal, A. (2002). Embolization of uterine artery in terminal stage cervical cancers. Cancer Investigation, 20(5-6), 754-8.

Yeung, A. R., Pugh, S. L., Klopp, A. H., Gil, K. M., Wenzel, L., Westin, S. N., Gaffney, D. K., Small, W. ,. J., ... Kachnic, L. A. (2020). Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study. Journal of Clinical Oncology, 38(15), 1685-1692.

Zanagnolo, V., Minig, L. A., Gadducci, A., Maggino, T., Sartori, E., Zola, P., & Landoni, F. (2009). Surveillance procedures for patients for cervical carcinoma: a review of the literature. International Journal of Gynecological Cancer, 19(3), 306-13.

Zhong, L., Li, K., Song, L., & Yin, R. (2022). The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis. Journal of Obstetrics and Gynaecology, 42(5), 830-837.

Zola, P., Fuso, L., Mazzola, S., Piovano, E., Perotto, S., Gadducci, A., Galletto, L., Landoni, F., ... Scambia, G. (2007). Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecologic Oncology, 107(1 Suppl 1), S150-4.

Zola, P., Macchi, C., Cibula, D., Colombo, N., Kimmig, R., Maggino, T., Reed, N., & Kesic, V. (2015). Follow-up in Gynecological Malignancies: A State of Art. International Journal of Gynecological Cancer, 25(7), 1151-64.